Literature DB >> 34150044

Jatrorrhizine can improve nerve cell injury induced by Aβ 25-35, acting through miR-223-3p/HDAC4 axis.

Wenbiao Duan1, Xue Chen1.   

Abstract

OBJECTIVE: The purpose of this research is to probe the mechanism of Jatrorrhizine (JAT) improving Aβ 25-35-induced nerve cell injury through the miR-223-3p/HDAC4 axis.
METHODS: SH-SY5Y cells were treated with Aβ 25-35 to simulate nerve injury in the pathogenesis of Alzheimer's disease (AD), and JAT-treated SH-SY5Y cells were assessed for HDAC4 and miR-223-3p. The HDAC4 and miR-223-3p levels were tested by qRT-PCR. Proliferation was determined through MTT. Apoptosis was assessed by flow cytometry, and the related indexes of oxidative stress (OS) were examined by an OS kit.
RESULTS: Compared with AD group, OD value increased, apoptosis rate decreased, and OS was inhibited in the AD+JAT group (all P<0.05). In SH-SY5Y cells, miR-223-3p can specifically inhibit the HDAC4 expression. The miR-223-3p expression increased and HDAC4 decreased after JAT acted on SH-SY5Y cells stimulated by Aβ 25-35 (all P<0.05). The addition of over-expression HDAC4 vector or miR-223-3p inhibitor could inhibit proliferation, and promote apoptosis and OS on the basis of JAT (all P<0.05). In addition, over-expressing miR-223-3p can suppress over-expressed HDAC4's effects on proliferation, apoptosis, and OS of SH-SY5Y cells (all P<0.05).
CONCLUSION: JAT can improve the nerve injury induced by Aβ 25-35 by up-regulating miR-223-3p and inhibiting the HDAC4 expression, suppress apoptosis and OS, and induce proliferation. This research further clarified the mechanism of JAT in AD. AJTR
Copyright © 2021.

Entities:  

Keywords:  Aβ 25-35; Jatrorrhizine; SH-SY5Y; miR-223-3p; nerve cell injury

Year:  2021        PMID: 34150044      PMCID: PMC8205821     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  22 in total

1.  ApoE4 and Aβ Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation.

Authors:  Abhik Sen; Thomas J Nelson; Daniel L Alkon
Journal:  J Neurosci       Date:  2015-05-13       Impact factor: 6.167

2.  MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis.

Authors:  Barbara Morquette; Camille A Juźwik; Sienna S Drake; Marc Charabati; Yang Zhang; Marc-André Lécuyer; Dylan A Galloway; Aline Dumas; Omar de Faria Junior; Nicolas Paradis-Isler; Mardja Bueno; Isabel Rambaldi; Stephanie Zandee; Craig Moore; Amit Bar-Or; Luc Vallières; Alexandre Prat; Alyson E Fournier
Journal:  Brain       Date:  2019-10-01       Impact factor: 13.501

3.  Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer's disease mouse models.

Authors:  Sarah M Neuner; Lynda A Wilmott; Brian R Hoffmann; Khyobeni Mozhui; Catherine C Kaczorowski
Journal:  Behav Brain Res       Date:  2016-06-02       Impact factor: 3.332

4.  Jatrorrhizine Hydrochloride alleviates tert-butyl hydroperoxide-induced endothelial cell injury through its anti-inflammatory activity and PPAR-γ activation.

Authors:  Guanji Wu; Ting Mu; Lihong Zhang; Xiaolin Chen
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2020-05-15       Impact factor: 1.770

5.  MicroRNA-29a-3p strengthens the effect of dexmedetomidine on improving neurologic damage in newborn rats with hypoxic-ischemic brain damage by inhibiting HDAC4.

Authors:  Wei Huang; Faling Xiao; Weijun Huang; Qiaosong Wei; Xisong Li
Journal:  Brain Res Bull       Date:  2020-11-21       Impact factor: 3.715

6.  Targeting MicroRNA-125b Promotes Neurite Outgrowth but Represses Cell Apoptosis and Inflammation via Blocking PTGS2 and CDK5 in a FOXQ1-Dependent Way in Alzheimer Disease.

Authors:  Jingcong Zhuang; Zhongjie Chen; Pingping Cai; Rong Wang; Qingwei Yang; Longling Li; Huili Yang; Renjing Zhu
Journal:  Front Cell Neurosci       Date:  2020-12-21       Impact factor: 5.505

Review 7.  Experimental Evidence of the Benefits of Acupuncture for Alzheimer's Disease: An Updated Review.

Authors:  Chao-Chao Yu; Yan-Jun Du; Shu-Qin Wang; Le-Bin Liu; Feng Shen; Li Wang; Yuan-Fang Lin; Li-Hong Kong
Journal:  Front Neurosci       Date:  2020-12-21       Impact factor: 4.677

Review 8.  RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs.

Authors:  Akihiko Nunomura; George Perry
Journal:  Oxid Med Cell Longev       Date:  2020-11-30       Impact factor: 6.543

Review 9.  Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer's disease.

Authors:  Weiwei Yu; Haiqiang Jin; Yining Huang
Journal:  Clin Sci (Lond)       Date:  2021-01-15       Impact factor: 6.124

10.  Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 transgenic mice.

Authors:  Sheng Wang; Wei Jiang; Ting Ouyang; Xiu-Yin Shen; Fen Wang; Yu-Hua Qu; Min Zhang; Tao Luo; Hua-Qiao Wang
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

View more
  2 in total

1.  Jatrorrhizine alleviates ulcerative colitis via regulating gut microbiota and NOS2 expression.

Authors:  Jia Ling Zhang; Min Na Zhang; Hong Gang Wang; Xiao Zhong Yang; Cheng Gong Yu
Journal:  Gut Pathog       Date:  2022-10-21       Impact factor: 5.324

Review 2.  Jatrorrhizine: A Review of Sources, Pharmacology, Pharmacokinetics and Toxicity.

Authors:  Furong Zhong; Yang Chen; Jia Chen; Hailang Liao; Yirou Li; Yuntong Ma
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.